Search clinical trials for: Olanzapine Tablets

Total 7006 results

Hospital Universitario de Fuenlabrada
Centro Nacional de Investigaciones Oncologicas CARLOS III

Active, not recruiting

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (Covid19COVINIB)

COVID-19 Pneumonia

Spain
Takeda

Withdrawn

A Phase 1, Single and Multiple Dose Study of TAK-137

Healthy Japanese Adult Male

Japan
Harmony Biosciences, LLC

Recruiting

A Study of Pitolisant in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Xgene Pharmaceutical Group

Recruiting

XG005 for Pain Control in Subjects Undergoing Bunionectomy

Acute Pain

United States
Abbisko Therapeutics Co, Ltd

Completed

ABSK091 Food Effect Study in Healthy Subjects

Health, Subjective | Food-drug Interaction

Taiwan
Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical(Australia) Pty Ltd.

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers

Healthy

Australia
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

Myelofibrosis

China
Fujian Akeylink Biotechnology Co., Ltd.
The First Hospital of Jilin University

Recruiting

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets

Pharmacokinetics | Food Affect | Single Ascending Dose | Maximum Applicable Dose

China
University of Colorado, Denver

Completed

Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD

Cognitive Dysfunction | Chronic Kidney Disease | Metabolic Acidosis

United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Withdrawn

Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) (COVID-19)

COVID-19 | Pneumonia

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
Valenta Pharm JSC

Completed

Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets

Healthy

Russian Federation
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Terminated

Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer

Gastric Cancer

China
Li Peng
Betta Pharmaceuticals Co., Ltd.

Completed

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Icotinib)

Neurofibromatosis Type 2 | Vestibular Schwannoma

China
Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets

Hepatitis B

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients

Functional Dyspepsia

China
Irish Response t/a Lifes2good
Stephens & Associates, Inc.

Completed

To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair

Hair Thinning

United States
Boehringer Ingelheim

Completed

Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI)

Venous Insufficiency
Novartis

Completed

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Hypertension

Hungary, Poland, United States, Belgium, Brazil
Point Therapeutics

Completed

Study of Talabostat in Advanced Melanoma

Melanoma | Skin Cancer

United States
Advenchen Laboratories Nanjing Ltd.

Recruiting

A Phase IIII Study of AL8326 in Small Cell Lung Cancer

Small Cell Lung Carcinoma

China
Peking University Third Hospital

Not yet recruiting

Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

China
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

United States
Sun Yat-sen University

Recruiting

CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC

Nasopharyngeal Carcinoma

China
Tongji Hospital

Not yet recruiting

Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.

Myelodysplastic Syndromes
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Not yet recruiting

A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Acute Graft-Versus-Host Disease

China
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects

Healthy Subjects

China
Regor Pharmaceuticals Inc.

Active, not recruiting

A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions

Myelofibrosis

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function

Hepatic Insufficiency | Healthy Subjects

China
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

A Study in Elderly Chinese Subjects With Underlying Diseases

Elderly Subjects With Underlying Diseases

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis

Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis(Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)

China
Haisco Pharmaceutical Group Co., Ltd.

Completed

Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN

Paresthesia | Diabetic Peripheral Neuropathy (DPN)

China
Nektar Therapeutics

Completed

Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain (SUMMIT-LTS)

Low Back Pain | Chronic Pain

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.

Renal Anemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

A Study of SYHA1805 in Healthy Adult Subjects

Healthy Subjects
Zhejiang Huahai Pharmaceutical Co., Ltd.

Completed

Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets

Major Depressive Disorder

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

Study of Aolanti Weikang Tablets in Healthy Volunteers

Functional Dyspepsia

China
shuai Mao

Completed

Danlou Tablets to Prevent Left Ventricular Remodeling

Acute Myocardial Infarction | Left Ventricular Remodeling
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers

Healthy

China
Otsuka Pharmaceutical Development & Commercialization...

Completed

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

United States
Estetra
ICON Clinical Research

Completed

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort)

Vasomotor Symptoms | Menopausal Symptoms

United States, Canada
Eli Lilly and Company

Completed

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

Schizophrenia | Bipolar Disorder

Germany, Greece, France
Eli Lilly and Company

Completed

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Schizophrenia

Japan
Emzor Pharmaceutical Industries Limited

Unknown

Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions

Bioequivalence
Chengdu University of Traditional Chinese Medicine
Chengdu PLA General Hospital; Chengdu First people's hospital

Completed

Acupuncture for Relieving Perimenopausal Symptoms

Perimenopause

China
Sequel Pharmaceuticals, Inc

Terminated

Phase 2 Study of Oral K201 for Prevention of AF Recurrence (ARCTIC-AF)

Atrial Fibrillation

Search clinical trials for: Olanzapine Tablets

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations